SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 82 filers reported holding SYNERON MEDICAL LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $48,000 | -54.7% | 5,683 | -61.3% | 0.01% | -54.5% |
| Q3 2016 | $106,000 | +307.7% | 14,681 | +330.7% | 0.01% | +450.0% |
| Q2 2016 | $26,000 | +766.7% | 3,409 | +769.6% | 0.00% | – |
| Q4 2015 | $3,000 | -86.4% | 392 | -86.9% | 0.00% | -100.0% |
| Q3 2015 | $22,000 | +2100.0% | 2,985 | +5046.6% | 0.00% | – |
| Q2 2015 | $1,000 | – | 58 | +56.8% | 0.00% | – |
| Q1 2015 | $0 | – | 37 | +19.4% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 31 | -97.2% | 0.00% | -100.0% |
| Q2 2014 | $11,000 | +83.3% | 1,113 | +135.3% | 0.00% | 0.0% |
| Q1 2014 | $6,000 | -82.9% | 473 | -83.5% | 0.00% | -83.3% |
| Q4 2013 | $35,000 | +191.7% | 2,866 | +114.2% | 0.01% | +500.0% |
| Q3 2013 | $12,000 | +200.0% | 1,338 | +201.4% | 0.00% | – |
| Q2 2013 | $4,000 | – | 444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 2,988,261 | $25,759,000 | 2.86% |
| NORTH TIDE CAPITAL, LLC | 2,150,000 | $18,533,000 | 1.94% |
| HOURGLASS CAPITAL, LLC | 838,900 | $7,231,000 | 1.26% |
| Baupost Group | 4,000,000 | $34,480,000 | 0.98% |
| DAFNA Capital Management LLC | 90,947 | $784,000 | 0.86% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 573,108 | $4,940,000 | 0.77% |
| Visium Asset Management, LP | 3,405,000 | $29,351,000 | 0.67% |
| PERRITT CAPITAL MANAGEMENT INC | 380,000 | $3,276,000 | 0.64% |
| Leonard Capital Management, Inc. | 112,109 | $966,000 | 0.38% |
| BRANDES INVESTMENT PARTNERS, LP | 1,765,018 | $15,214,000 | 0.20% |